Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Asthma and COPD Drugs Market Report: Trends, Forecast and Competitive Analysis to 2030
... the asthma and COPD markets. The global asthma and COPD drugs market is expected to reach an estimated $40.8 billion by 2030 with a CAGR of 4.3% from 2024 to 2030. The major drivers for ... Read More
-
Cutaneous and Systemic Leishmaniasis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and
... Africa) The global Cutaneous and Systemic Leishmaniasis market is on an upward trajectory over the forecast period 2024-2031. This growth can be attributed to several key factors that are driving the market's expansion. High Clinical ... Read More
-
Biosimulation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... technique harnessing computer programs to simulate biological processes, is revolutionizing the field of drug discovery and development. This innovative tool allows researchers to predict the outcomes of experiments related to drug development, significantly reducing the ... Read More
-
Vaginitis Therapeutics Global Market Report 2024
... Hospitals; Ambulatory Surgical Centers; Specialized Gynecology Centers; ClinicsCovering: Pfizer Inc.; Merck & Co Inc.; Novartis AG; Bayer AG; Lupin Pharmaceuticals Inc. Vaginitis Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers ... Read More
-
Global Amino Acid Analyzer for Industrial, Preclinical, and Clinical Usage Market 2024-2028
... CAGR of 5.76% during the forecast period. The report on the amino acid analyzer for the industrial, preclinical, and clinical usage market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, ... Read More
-
Top Ten Suppliers of Synthetic Biology Technology
... driving the industry growth that allows these companies to succeed. The market is divided into segments and by application/industry as follows By product Enabling Products. Biologic Components. Integrated systems Enabled Products. By Industry R&D Tools. ... Read More
-
Single-Cell Multi-Omics Market by Type (Single Cell Genomics, Single Cell Metabolomics, Single Cell Proteomics), Technique (Single-Cell Analysis, Single-Cell Isolation & Dispensing), Application, End User - Global Forecast 2024-2030
... at USD 2.92 billion in 2023 and expected to reach USD 3.18 billion in 2024, at a CAGR 10.65% to reach USD 5.93 billion by 2030. Global Single-Cell Multi-Omics Market FPNV Positioning Matrix The FPNV ... Read More
-
Schizophrenia Therapeutics Market by Therapeutic Class (Second Generation, Third Generation), Administration (Injectable, Oral), Distribution Channel - Global Forecast 2024-2030
... reach USD 8.08 billion in 2024, at a CAGR 4.94% to reach USD 11.06 billion by 2030. Global Schizophrenia Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Schizophrenia Therapeutics ... Read More
-
Alzheimer's Disease Diagnostics & Therapeutics Market by Product (Diagnostics, Therapeutics), Disease Stage (Early, Moderate, Severe), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 7.26 billion in 2024, at a CAGR 8.00% to reach USD 11.57 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Alzheimer's Disease ... Read More
-
Central Nervous System Therapeutics Market by Diseases (Cancer, Degenerative Diseases, Infectious Diseases), Drug Class (Analgesics, Anesthetics, Anti-Epileptics), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 76.41 billion in 2024, at a CAGR 9.37% to reach USD 131.39 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Central ... Read More
-
Lifestyle Drugs Market by Therapeutic Type (Dermatology, Insomnia, Obesity), Form (Creams, Gels, Oral Syrups), Distribution - Global Forecast 2024-2030
... reach USD 22.14 billion in 2024, at a CAGR 5.82% to reach USD 31.12 billion by 2030. Global Lifestyle Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Lifestyle Drugs ... Read More
-
Rheumatology Therapeutics Market by Indication (Ankylosing Spondylitis, Gout, Osteoarthritis), Distribution Channel (Offline Mode, Online Stores) - Global Forecast 2024-2030
... reach USD 33.24 billion in 2024, at a CAGR 6.51% to reach USD 48.58 billion by 2030. Global Rheumatology Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Rheumatology Therapeutics ... Read More
-
Animal Biotechnology Market by Product (Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs), Application (Development of Animal Pharmaceuticals, Food Safety & Drug Development, Preventive Care for Animals) - Global Forecast 2024-2030
... was estimated at USD 28.64 billion in 2023 and expected to reach USD 31.04 billion in 2024, at a CAGR 8.46% to reach USD 50.59 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Eczema Therapeutics Market by Treatment (Antibiotics, Antihistamines, Calcineurin Inhibitors), Distribution Channel (Hospital & Clinics, Online Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... and expected to reach USD 7.49 billion in 2024, at a CAGR 9.59% to reach USD 13.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Eczema Therapeutics Market. ... Read More
-
Parkinson's Disease Therapeutics Market by Type (Intestinal Infusion, Oral, Subcutaneous), Drug Class (Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor), Distribution Channel, End Use - Global Forecast 2024-2030
... 3.15 billion in 2023 and expected to reach USD 3.49 billion in 2024, at a CAGR 10.88% to reach USD 6.51 billion by 2030. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market FPNV Positioning Matrix The FPNV ... Read More
-
Cell Cryopreservation Market - By Product Type (Cryoprotectant Agents, Equipment), Cell Type (Stem Cells, Oocytes & Embryotic Cells, Sperm Cells), Application (Drug Discovery & Development, Regenerative Medicine), End-use - Global Forecast, 2024 - 2032
... Cell Cryopreservation Market will register a 21.5% CAGR from 2024 to 2032 due to advancements in biobanking technologies and the expanding applications of stem cell research. With the launch of new laboratories, there's an increased ... Read More
-
Middle East & Africa Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... End User (Hospital & Clinics and Ambulatory Surgical Center) The Middle East & Africa glioma treatment market is expected to grow from US$ 127.60 million in 2022 to US$ 243.45 million by 2030. It is ... Read More
-
Gastroesophageal Reflux Disease Therapeutics Market by Type (Branded, Generics), Drug Class (Aminosalicylates, Anti-Diarrheal, Anti-Emetics), Application - Global Forecast 2024-2030
... expected to reach USD 6.14 billion in 2024, at a CAGR 5.01% to reach USD 8.24 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Gastroesophageal Reflux Disease Therapeutics ... Read More
-
North America Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... (Hospital & Clinics and Ambulatory Surgical Center) The North America glioma treatment market is expected to grow from US$ 2,179.88 million in 2022 to US$ 4,377.38 million by 2030. It is estimated to grow at ... Read More
-
Label-free Array System Market by Technique (Atomic Force Microscopy, Ellipsometry Techniques, Enthalpy Array), Application (Biomolecular Interactions, Detection of Disease Biomarkers, Drug Discovery), End User - Global Forecast 2024-2030
... estimated at USD 1.38 billion in 2023 and expected to reach USD 1.49 billion in 2024, at a CAGR 8.11% to reach USD 2.38 billion by 2030. Global Label-free Array System Market FPNV Positioning Matrix ... Read More
-
Dementia Drugs Market by Indications (Alzheimer's Disease, Lewy Body Dementia, Parkinsons Disease Dementia), Drug Class (Cholinesterase Inhibitors, Glutamate Inhibitors, MAO Inhibitors) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 10.78 billion in 2024, at a CAGR 10.39% to reach USD 19.58 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Antiviral Drugs Market by Drug Type (Branded Drugs, Generic Drugs), Therapeutics (Acquired Immunodeficiency Syndrome Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics), End Use - Global Forecast 2024-2030
... at USD 56.22 billion in 2023 and expected to reach USD 59.84 billion in 2024, at a CAGR 6.54% to reach USD 87.61 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast
... billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Prostate Cancer Therapeutics Market by Drug Class (Chemotherapy, Hormonal Therapy, Immunotherapy), Distribution Channel (Drug Stores & Retail Pharmacies, Hospitals Pharmacies, Online Pharmacies) - Global Forecast 2024-2030
... USD 10.00 billion in 2023 and expected to reach USD 10.62 billion in 2024, at a CAGR 6.32% to reach USD 15.36 billion by 2030. Global Prostate Cancer Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Bioinformatics Market by Product (Bioinformatics Platform, Bioinformatics Services, Knowledge Management Tools), Application (Chemoinformatics, Genomics, Metabolomics), End-User - Global Forecast 2024-2030
... reach USD 32.03 billion in 2024, at a CAGR 18.51% to reach USD 88.84 billion by 2030. Global Bioinformatics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioinformatics Market. It ... Read More
Research Assistance
